Polsinelli Podcasts - FDA Denies Amgen Citizen Petition in Biosimilar Dispute
In September 2014, the FDA published the first edition of the Purple Book: Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations (“Purple Book”), the...more